Mefloquine and Beyond: Assessing Fda-Approved Drugs for Repurposed Antifungal Efficacy
Ishita Mirchandani +4 more
openalex +1 more source
Tolerance of Plasmodium falciparum mefloquine-resistant clinical isolates to mefloquine-piperaquine with implications for triple artemisinin-based combination therapies. [PDF]
Roesch C +16 more
europepmc +1 more source
Crystal structure and Hirshfeld surface analysis of [(<i>R</i>,<i>S</i>)-2,8-bis-(tri-fluoro-meth-yl)quinolin-4-yl](piperidin-2-yl)methanol methanol monosolvate. [PDF]
Awasabisah D +3 more
europepmc +1 more source
Screening and transcriptomic analysis of anti-<i>Sporothrix globosa</i> targeting AbaA. [PDF]
Wang Y +5 more
europepmc +1 more source
Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine-pyrimethamine plus artesunate-pyronaridine. [PDF]
Mombo-Ngoma G +10 more
europepmc +1 more source
A review on molecular markers of <i>Plasmodium falciparum</i>. [PDF]
Abebe W, Woldesenbet D.
europepmc +1 more source
Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria.
Karl H. Rieckmann +5 more
openalex
Clinical and epidemiological profiles of confirmed malaria cases in the state of Pernambuco, Brazil, from 2001 to 2022. [PDF]
Guedes DL +5 more
europepmc +1 more source

